---
figid: PMC9168430__fphar-13-893567-g003
figtitle: 'Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current
  Evidence'
organisms:
- Escherichia coli
- Lactiplantibacillus plantarum
- Campylobacter jejuni
- Lacticaseibacillus casei
- Faecalibacterium prausnitzii
- Akkermansia muciniphila
- Lacticaseibacillus rhamnosus
- Lacticaseibacillus rhamnosus GG
- Clostridium butyricum
- Bacteroides sp.
- Bifidobacterium dentium Bd1
- Bifidobacterium animalis subsp. lactis BB-12
- Paenalcaligenes hominis
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Saccharomyces cerevisiae
- gut metagenome
- Candida albicans
- Macaca mulatta
- human gut metagenome
pmcid: PMC9168430
filename: fphar-13-893567-g003.jpg
figlink: /pmc/articles/PMC9168430/figure/F3/
number: F3
caption: 'Dietary tryptophan metabolism follows three major pathways in the gastrointestinal
  tract: 1) the kynurenine pathway via IDO1, which can be activated by gut microbial
  dysbiosis; 2) production of serotonin in enteroendocrine cells and indirect regulation
  of tryptophan availability under the control of gut microbiota; and 3) the direct
  conversion to AhR ligands by gut microbiota. The figure shows an altered dynamic
  of the tryptophan metabolic pathway in IBS, BD, and germ-free mice based on the
  available clinical data. Weights of arrows indicate the strength of pathway activation.
  IDO1, indoleamine 2,3-dioxygenase 1; TDO, tryptophan 2,3-dioxygenase; TpH1, tryptophan
  hydroxylase 1; AhR, aryl hydrocarbon receptor.'
papertitle: 'Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder:
  Current Evidence.'
reftext: Wenyu Dai, et al. Front Pharmacol. 2022;13:893567.
year: '2022'
doi: 10.3389/fphar.2022.893567
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: bipolar disorder | gut microbiota | cognitive function | gut-brain axis
  | psychobiotic
automl_pathway: 0.9511049
figid_alias: PMC9168430__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Macaca mulatta
- Mus musculus
redirect_from: /figures/PMC9168430__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9168430__fphar-13-893567-g003.html
  '@type': Dataset
  description: 'Dietary tryptophan metabolism follows three major pathways in the
    gastrointestinal tract: 1) the kynurenine pathway via IDO1, which can be activated
    by gut microbial dysbiosis; 2) production of serotonin in enteroendocrine cells
    and indirect regulation of tryptophan availability under the control of gut microbiota;
    and 3) the direct conversion to AhR ligands by gut microbiota. The figure shows
    an altered dynamic of the tryptophan metabolic pathway in IBS, BD, and germ-free
    mice based on the available clinical data. Weights of arrows indicate the strength
    of pathway activation. IDO1, indoleamine 2,3-dioxygenase 1; TDO, tryptophan 2,3-dioxygenase;
    TpH1, tryptophan hydroxylase 1; AhR, aryl hydrocarbon receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IDO1
  - AHR
  - TPH1
  - IL22
  - DLX3
  - TDO2
  - MICE
  - Ido1
  - Ahr
  - Tph1
  - Il22
  - Tdo2
  - Gusb
  - Casp14
---
